您要查找的是不是：
- Ukrainian Academy of Medical Sciences: Kiev. 乌克兰医学科学院:基辅。
- Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China. 北京中国医学科学院癌症研究所。
- Fang Fude : Professor ，Institute of Basic Medical Sciences， Chinese Academy of Medical Sciences ，Beijing 100005. 方福德：教授，中国医学科学院基础医学研究所，北京100005。
- This work was conducted at the CUHK Epithelial Cell Biology Research Centre and in collaboration with Zhejiang Academy of Medical Sciences. 该项研究是在香港中文大学上皮细胞生物学研究中心进行,并与浙江医学科学院合作完成。
- METHODS: From January 2004 to August 2006,the experiment was completed in the Institute of Bioengineering,Zhejiang Academy of Medical Sciences. 方法:实验于2004-01/2006-08在浙江省医学科学院生物工程所完成。
- Zhang Zhengyan,M.D.Doctor;Ma Jing,Assistant;Zhang Jingbo, Professor: Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Beijing 100005. 章正琰,博士；马静，助教；章静波,研究员:中国医学科学院基础研究所，北京100005。
- METHODS: Records of 22 patients with PTL treated in Cancer Hospital, Chinese Academy of Medical Sciences from Jan.1990 to Jan. 2004 were retrospectively analyzed. 方法:分析中国医学科学院中国协和医科大学肿瘤医院1990年1月至2004年1月收治的22例PTL患者的临床和病理资料。
- In the Chinese Academy of Medical Sciences,women make up over 40 percent of scientists with senior professional titles,and 47.3 percent of the 112 academy-level key research projects are in the charge of women. 在中国医学科学院具有高级专业技术职称的科学家中，女性占40%25以上；院级112个重点科研课题中，女课题负责人占47.;3%25。
- In the Chinese Academy of Medical Sciences, women make up over 40 percent of scientists with senior professional titles, and 47.3 percent of the 112 academy-level key research projects are in the charge of women. 在中国医学科学院具有高级专业技术职称的科学家中，女性占40%25以上； 院级112个重点科研课题中，女课题负责人占47.;3%25。
- Chinese Academy of Medical Sciences 中国医学科学院
- Chinese Academy of Medical Sciences, CAMS 中国医学科学院
- MATERIALS:The experiment was conducted from May 2003 to March 2004 at Pathological Laboratory of Shandong Provincial Academy of Medical Science. 对象:实验于2003-05/2004-03在山东省医学科学院病理实验室进行。
- METHODS:The data of 76 patients with SCC of the anterior tongue who were never treated before were obtained from Chinene Academy of Medical Science Cancer Hospital. 方法:回顾性分析舌SCC -76 例临床病理资料。
- Imrecoxib, one of 3,4-diaryl-3-pyrrolin-2-ones, was synthesized by the Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, which is a specific inhibitor of cyclooxygenase-2 in developing. 艾瑞昔布(imrecoxib)是我国研发的一个环氧化酶-2(COX-2)特异性抑制剂，它属于含有磺酰基的吡咯烷酮类化合物。
- METHODS: The clinical and pathological records of 15 PBL patients admitted in the Cancer Hospital, Chinese Academy of Medical Science from January 1986 to December 2003 were analyzed. 方法回顾性分析我院1986年1月至2003年12月诊治的15例PBL患者的临床和病理资料。
- Peking Union Medical College, Chinese Academy of Medical Sciences 中国医学科学院协和医科大学
- Institute of Medicinal Biotech, China Academy Of Medical Sciences 中国医学科学院医药生物技术研究所
- Islamic Republic of Iran Academy of Medical Sciences 伊朗伊斯兰共和国医学科学院
- Institute of Materia Medica, Chinese Academy of Medical Sciences 中国医学科学院药物研究所
- School of Medical Sciences University of Otago. 大学医学院。
